In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The makers of Bhool Bhulaiyaa 3 released the teaser of the film on Friday, September 27. The teas
The threat of corona persists around the world. These days Omicron's new subtype or substrain XBB
India Weather Update: Due to heavy rains and floods in many parts of the country, life is disturb
Pakistan, which dreamed of destroying India, has now become one of the 10 most indebted countries
Yashasvi Jaiswal's bat has played very well in the four Test matches played against England so fa
After the uproar during the survey of Shahi Jama Masjid on 24 November in Sambhal district of Utt
Rashtriya Swayamsevak Sangh (RSS) chief Mohan Bhagwat was invited to attend the consecration cere
The written examination for direct recruitment to 60,244 posts of constable civil police in UP Po
Search in Tihar Jail after Musewala's murder, 'illegal goods' found from Lawrence Bishnoi's cell
A search operation is underway at Tihaj Jail following reports that Bishnoi was behind the murder
In Rajasthan, there is a political tussle between Chief Minister Ashok Gehlot and former Deputy C
